James T. Dalton
James Tilmon Dalton is an American pharmacist. He is a Dean and Professor of Pharmaceutical Sciences at the University of Michigan.Career
After earning his PhD, Dalton joined the pharmaceutical staff at Kettering Medical Center before being appointed assistant professor at the University of Tennessee. As a professor at the University of Tennessee, Dalton was part of a research group that recorded selective androgen receptor modulators. In 1997, Dalton’s group published the first report on SARMs, which was used to research and create a class of potential drugs to treat age and disease-related muscle loss.
From there, he was promoted to associate professor and transferred to the Ohio State College of Pharmacy faculty.
Dalton was eventually promoted to full professor and Chair of the Division of Pharmaceutics and Pharmaceutical Chemistry. While at OSU, he was elected a Fellow of the American Association of Pharmaceutical Scientists. The year following his fellowship election, Dalton left OSU to become Chief Scientific Officer at GTx Incorporated. Dalton left GTx in 2014 to become the Dean of Pharmaceutical Sciences at the University of Michigan. The next year, he was elected a fellow of the American Association for the Advancement of Science.
In 2019, Dalton was one of three UMich faculty members elected to National Academy of Medicine.
